title: [Pathology and treatment of autism spectrum disorders].
authors: Hiroko
authors: H
authors: Kotajima-Murakami
authors: Atsushi
authors: A
authors: Sato
authors: Kazutaka
authors: K
authors: Ikeda
mesh_terms: D000818:Animals; D002659:Child Development Disorders, Pervasive / Q000188:drug therapy* / Q000235:genetics*; D004195:Disease Models, Animal; D039642:Eukaryotic Initiation Factors / Q000502:physiology; D051860:Fragile X Messenger Ribonucleoprotein 1; D051379:Mice; D009419:Nerve Tissue Proteins / Q000502:physiology; D025542:Neurofibromin 1 / Q000502:physiology; D010121:Oxytocin / Q000502:physiology / Q000627:therapeutic use; D051059:PTEN Phosphohydrolase / Q000235:genetics / Q000502:physiology; D020123:Sirolimus / Q000627:therapeutic use; D058570:TOR Serine-Threonine Kinases / Q000502:physiology; D000077004:Tuberous Sclerosis Complex 1 Protein; D000077005:Tuberous Sclerosis Complex 2 Protein; D025521:Tumor Suppressor Proteins / Q000502:physiology
chemical_list: D039642:Eukaryotic Initiation Factors; D051860:Fragile X Messenger Ribonucleoprotein 1; D009419:Nerve Tissue Proteins; D025542:Neurofibromin 1; D010121:Oxytocin; D051059:PTEN Phosphohydrolase; D020123:Sirolimus; D058570:TOR Serine-Threonine Kinases; D000077004:Tuberous Sclerosis Complex 1 Protein; D000077005:Tuberous Sclerosis Complex 2 Protein; D025521:Tumor Suppressor Proteins; C104151:EIF4EBP2 protein, human; C497683:FMR1 protein, human; C494929:PTEN protein, human